Official UK procurement notice
Biofoundry DNA Script SYNTAX equipment (and optional Hamilton liquid handler)
Authority: CENTRE FOR PROCESS INNOVATION LIMITED (Public body)
What is being bought
Published requirement descriptionCPI require equipment to manufacture DNA to support the Biofoundry programme. This equipment is specifically designated in the business case and forms part of the programme from OLS via Innovate UK.
This equipment forms the first stage of the Biofoundry process, producing the synthetic DNA templates that are essential to supply in-vitro transcription (IVT) and the subsequent RNA-LNP manufacturing workflow
The lotProcurement structure
single lot · no lot value publishedLot #1Awarded
Procedure terms & legal framework
From the official record- Procedure method
- Direct award
- Legal basis
- UKPGA · 2023/54 Procurement Act 2023
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 17 Oct 2025, 09:05 BST
- Last source update
- 5 Jan 2026, 11:54 GMT
- Authority reference
3699- FTS notice number
2026/S 000-000241- Latest notice
- Contract details notice (UK7)
- Delivery area
- Not published
- Official registry OCID
ocds-h6vhtk-05ce75Find a Tender
- Why no open competition
- Single Suppliers Unique Work Art Performance
- Published justification
The equipment is a prototype developed specifically to enable the Biofoundy the capability of being a 'DNA printer'. Forming a core element of the Biofoundry, it will allow bespoke DNA to be printed to support the manufacture of RNA-LNP. It will allow multiple, complex DNA candidates to be manufactured quickly, in house for a reasonable price. Facilitating the Biofoundry model. The UK Biofoundry forms part of the broader worldwide Biofoundy network. Initiated by the charity, Wellcome Leap inc, the vision is to enable early-stage academics and SME's access to cost effective RNA-LNP to enable more shots on goal with this life changing technology while enhancing the worlds pandemic readiness. The Biofoundry network, via Wellcome Leap, has directly funded development of the UK Biofoundry equipment
How it was run
Official notice- Submission deadline
- —
Timeline
6 Nov 2025 → 5 Jan 2026 · 2 dates- Standstill ends351 days ago6 Nov 2025, 23:59 GMT
- Notice published291 days ago5 Jan 2026, 11:54 GMT
Notice history
4 events · 3 releases on Find a Tender · since 17 Oct 2025- Transparency notice published17 Oct 2025, 09:05 BSTUK5
- Contract award notice published28 Oct 2025, 10:46 GMTUK6
- Contract signature expected12 Nov 2025, 23:59 GMTscheduled
- Contract details notice published5 Jan 2026, 11:54 GMTUK7
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| DNA ScriptBiofoundry - DNA Script SYNTAX equipment (and Hamilton liquid handler)14 Nov 2025 – 30 Sept 2028 | £2,040,000 inc. VAT | 28 Oct 2025 | Awarded |
Contracts
Biofoundry - DNA Script SYNTAX equipment (and Hamilton liquid handler) · DNA Script
- Signed
- 3 Dec 2025
- Value
- £2,500,856 inc. VAT
- Period
- 3 Dec 2025 – 30 Sept 2028
- Status
- active
Contracting authority & participating public bodies
Bidders & participating suppliers
1 commercial party on the notice- DNA SCRIPTAwarded supplier
Official documents & specifications (3)
Official links; attachments are not copiedNotices published for this procedure
- Contract details notice Contract details notice on Find a Tender
- Contract award notice Contract award notice on Find a Tender
- Transparency notice Transparency notice on Find a Tender